Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR10A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,778
Award facts
- Contract value 100% obligated
- $12,778.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp (ABDC), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on January 14, 2026, for the supply of Mounjaro 5 mg/0.5 mL pens in 0.5 mL quantities. This firm fixed-price delivery order carries a ceiling value of $12,778.40 with an ultimate completion date of January 15, 2026, and was awarded on a non-set-aside, competitive basis. The award represents a task order placed under ABDC's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a comprehensive Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
This delivery order supports the military healthcare system's pharmaceutical supply chain by providing a branded diabetes medication for service members and military beneficiaries worldwide. Mounjaro is a GLP-1 receptor agonist used for diabetes management, consistent with the broad therapeutic portfolio that Cencora supplies to federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. The rapid completion timeline reflects the time-sensitive nature of pharmaceutical delivery orders under the DLA's medical supply operations, demonstrating the efficiency of the established vendor-agency relationship for critical medication fulfillment.
Quick answers
Who was awarded contract SPE2DR26FR10A?
SPE2DR26FR10A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FR10A worth?
The government has obligated $12,778 on SPE2DR26FR10A.
Is contract SPE2DR26FR10A an order under another contract?
Yes. SPE2DR26FR10A is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR10A competed?
The extent of competition for SPE2DR26FR10A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award